BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21791049)

  • 1. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
    Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
    Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
    Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
    Hu K; Callen DF; Li J; Zheng H
    Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
    McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
    Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.
    Villaseñor A; Ballard-Barbash R; Ambs A; Bernstein L; Baumgartner K; Baumgartner R; Ulrich CM; Hollis BW; McTiernan A; Neuhouser ML
    Cancer Causes Control; 2013 Apr; 24(4):759-67. PubMed ID: 23361338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
    Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
    JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum concentration of vitamin D and 1-year mortality in stroke patients.
    Daubail B; Jacquin A; Guilland JC; Khoumri C; Aboa-Eboulé C; Giroud M; Béjot Y
    Cerebrovasc Dis; 2014; 37(5):364-7. PubMed ID: 24970287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
    Ginde AA; Scragg R; Schwartz RS; Camargo CA
    J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
    Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
    Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.
    Goodwin PJ; Ennis M; Pritchard KI; Koo J; Hood N
    J Clin Oncol; 2009 Aug; 27(23):3757-63. PubMed ID: 19451439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of very low serum 25-hydroxyvitamin D
    Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer.
    Webb PM; de Fazio A; Protani MM; Ibiebele TI; Nagle CM; Brand AH; Blomfield PI; Grant P; Perrin LC; Neale RE;
    Am J Clin Nutr; 2015 Jul; 102(1):109-14. PubMed ID: 25971716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
    Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
    Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.
    Cheney CP; Thorand B; Huth C; Berger K; Peters A; Seifert-Klauss V; Kiechle M; Strauch K; Quante AS
    Oncol Res Treat; 2018; 41(3):117-121. PubMed ID: 29485414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.